Elevated levels of TREM2 in cerebrospinal fluid have been associated with increased amyloid plaque burden, neurodegeneration, and cognitive decline in individuals with Alzheimer’s disease. Here, TREM2 is linked to early-onset autosomal dominant Alzheimer disease.